(Q35534964)

8 August 2017

1 reference

title

Gut fungal microbiota: the Yin and Yang of inflammatory bowel disease (English)

1 reference

inflammatory bowel diseases

8 August 2017

main subject

0 references

2

Bruno Lamas

1 reference

8 August 2017

Harry Sokol

5

0 references

Giuseppina Liguori

series ordinal

3

object named as

Giuseppina Liguori

1 reference

8 August 2017

Mathias L Richard

1

1 reference

8 August 2017

Thomas W Hoffmann

series ordinal

4

1 reference

8 August 2017

publication date

1 March 2015

1 reference

Inflammatory Bowel Diseases

8 August 2017

published in

1 reference

8 August 2017

volume

21

1 reference

8 August 2017

issue

3

1 reference

8 August 2017

page(s)

656-665

1 reference

Genetics and pathogenesis of inflammatory bowel disease

8 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000261

The gut microbiota in IBD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000261

Low counts of Faecalibacterium prausnitzii in colitis microbiota.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000261

The gut microbiota--masters of host development and physiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000261

Emerging roles of the microbiome in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000261

The role of metagenomics in understanding the human microbiome in health and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000261

The microbiota-gut-brain axis: neurobehavioral correlates, health and sociality

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000261

A human gut microbial gene catalogue established by metagenomic sequencing

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000261

The emerging world of the fungal microbiome

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000261

Topographic diversity of fungal and bacterial communities in human skin

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000261

Molecular analysis of fungal microbiota in samples from healthy human skin and psoriatic lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000261

Characterization of the vaginal micro- and mycobiome in asymptomatic reproductive-age Estonian women

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000261

Characterization of the vaginal fungal flora in pregnant diabetic women by 18S rRNA sequencing

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000261

Characterization of the oral fungal microbiome (mycobiome) in healthy individuals

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000261

Plant and fungal diversity in gut microbiota as revealed by molecular and culture investigations

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000261

Nuclear ribosomal internal transcribed spacer (ITS) region as a universal DNA barcode marker for Fungi

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000261

The airway microbiota in cystic fibrosis: a complex fungal and bacterial community--implications for therapeutic management

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000261

A tool kit for quantifying eukaryotic rRNA gene sequences from human microbiome samples

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000261

CloVR-ITS: Automated internal transcribed spacer amplicon sequence analysis pipeline for the characterization of fungal microbiota

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000261

Micro-eukaryotic diversity of the human distal gut microbiota: qualitative assessment using culture-dependent and -independent analysis of faeces.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000261

Bacterial and fungal microbiota in relation to probiotic therapy (VSL#3) in pouchitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000261

Correlation between gastrointestinal fungi and varying degrees of chronic hepatitis B virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000261

Use of 18S ribosomal DNA polymerase chain reaction-denaturing gradient gel electrophoresis to study composition of fungal community in 2 patients with intestinal transplants.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000261

Fungi and inflammatory bowel diseases: Alterations of composition and diversity

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000261

Molecular typing of fecal eukaryotic microbiota of human infants and their respective mothers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000261

Effects of almond and pistachio consumption on gut microbiota composition in a randomised cross-over human feeding study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000261

Immune status, antibiotic medication and pH are associated with changes in the stomach fluid microbiota.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000261

Molecular detection of eukaryotes in a single human stool sample from Senegal

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000261

Archaea and fungi of the human gut microbiome: correlations with diet and bacterial residents

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000261

Candida albicans and bacterial microbiota interactions in the cecum during recolonization following broad-spectrum antibiotic therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000261

Pathogenesis of invasive fungal infections.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000261

Distinguishing Galactomyces citri-aurantii from G. geotrichum and characterizing population structure of the two postharvest sour rot pathogens of fruit crops in California

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000261

Skin diseases associated with Malassezia yeasts: facts and controversies

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000261

Lung-enriched organisms and aberrant bacterial and fungal respiratory microbiota after lung transplant.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000261

Abundant and diverse fungal microbiota in the murine intestine

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000261

Fungi of the murine gut: episodic variation and proliferation during antibiotic treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000261

Interactions between commensal fungi and the C-type lectin receptor Dectin-1 influence colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000261

The intestinal microbiota in inflammatory bowel diseases: time to connect with the host

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000261

Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000261

Dysfunction of the intestinal microbiome in inflammatory bowel disease and treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000261

Antibody to selected strains of Saccharomyces cerevisiae (baker's and brewer's yeast) and Candida albicans in Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000261

Anti-Saccharomyces cerevisiae antibodies (ASCA), phenotypes of IBD, and intestinal permeability: a study in IBD families.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000261

Anti-Saccharomyces cerevisiae mannan antibodies combined with antineutrophil cytoplasmic autoantibodies in inflammatory bowel disease: prevalence and diagnostic role

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000261

Antibodies against laminaribioside and chitobioside are novel serologic markers in Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000261

Selected loss of tolerance evidenced by Crohn's disease-associated immune responses to auto- and microbial antigens

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000261

Toll-like receptors and fungal infections: the role of TLR2, TLR4 and MyD88 in paracoccidioidomycosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000261

Card9 controls a non-TLR signalling pathway for innate anti-fungal immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000261

Candida albicans colonization and ASCA in familial Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000261

Secukinumab, a human anti-IL-17A monoclonal antibody, for moderate to severe Crohn's disease: unexpected results of a randomised, double-blind placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000261

The effects of itraconazole on inflammatory bowel disease activity in patients treated for histoplasmosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000261

Colonization of Mice byCandida albicansIs Promoted by Chemically Induced Colitis and Augments Inflammatory Responses through Galectin‐3

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000261

Genotypic and physiological characterization of Saccharomyces boulardii, the probiotic strain of Saccharomyces cerevisiae

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000261

Systematic review and meta-analysis of Saccharomyces boulardii in adult patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000261

Saccharomyces boulardii ameliorates Citrobacter rodentium-induced colitis through actions on bacterial virulence factors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000261

The effect of Saccharomyces boulardii on Candida albicans-infected human intestinal cell lines Caco-2 and Intestin 407.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000261

Capric acid secreted by S. boulardii inhibits C. albicans filamentous growth, adhesion and biofilm formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000261

Probiotic yeast inhibits VEGFR signaling and angiogenesis in intestinal inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000261

Saccharomyces boulardiidecreases inflammation and intestinal colonization byCandida albicansin a mouse model of chemically-induced colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000261

Effect of Saccharomyces boulardii and Bacillus subtilis B10 on intestinal ultrastructure modulation and mucosal immunity development mechanism in broiler chickens

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000261

Saccharomyces boulardii inhibits ERK1/2 mitogen-activated protein kinase activation both in vitro and in vivo and protects against Clostridium difficile toxin A-induced enteritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000261

Saccharomyces boulardii inhibits inflammatory bowel disease by trapping T cells in mesenteric lymph nodes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000261

Saccharomyces boulardii improves intestinal epithelial cell restitution by inhibiting αvβ5 integrin activation state

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000261

Saccharomyces boulardii improves intestinal cell restitution through activation of the α2β1 integrin collagen receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000261

CARD9 signaling in the innate immune response

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000261

Oral mycobiome analysis of HIV-infected patients: identification of Pichia as an antagonist of opportunistic fungi

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000261

Tryptophan catabolites from microbiota engage aryl hydrocarbon receptor and balance mucosal reactivity via interleukin-22.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000261

Immunity to fungal infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000261

10.1097/MIB.0000000000000261

21 January 2018

Identifiers

DOI

1 reference

8 August 2017

1 reference